BioGenex, Inc. and Abbott Molecular, Inc. Conclude Successful Partnership
3/4/2013 10:07:05 AM
More...
|
Abbott Molecular, Inc. Forms Pact With Janssen Biotech Inc. for Leukemia Test
2/21/2013 7:28:03 AM
More...
|
Abbott Laboratories (ABT) and Merck & Co., Inc. (MRK) Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
3/6/2012 10:31:23 AM
More...
|
Abbott Molecular, Inc. Expands Agreement With GlaxoSmithKline (GSK) to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen
11/28/2011 7:08:02 AM
More...
|
Abbott Molecular, Inc.'s Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
10/25/2011 6:16:22 AM
More...
|
China Department of Health Issues Recall for Abbott Molecular, Inc.'s Preparation System
10/14/2011 8:55:56 AM
More...
|
Abbott Molecular, Inc. Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
8/29/2011 7:01:33 AM
More...
|
FDA Clears Abbott Molecular, Inc.'s Genetic FISH Panel for Leukemia Patient Prognosis
8/22/2011 6:50:49 AM
More...
|
Abbott Molecular, Inc.'s Ibis Technology Identified Fatal Disease Organism in Afghanistan
2/7/2011 1:01:42 PM
More...
|
Abbott Molecular, Inc. Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
9/1/2010 8:25:47 AM
More...
|
|